Loop Capital analyst: Amazon’s PillPack deal is “a Trojan Horse”
Amazon's PillPack acquisition allows it to bypass some of the hurdles it would have to entering the retail pharmacy industry, Loop Capital's Anthony Chukumba said. On Wednesday, Loop raised its price target on Amazon to $1,900 from $1,800. Walgreens, CVS and Rite Aid are down on the news.